124 related articles for article (PubMed ID: 7918847)
1. Optimisation of a new continuous UV assay for the determination of blood coagulation factor XIII activity in human plasma.
Heins M; Fahron U; Withold W; Rick W
Eur J Clin Chem Clin Biochem; 1994 Jun; 32(6):479-83. PubMed ID: 7918847
[TBL] [Abstract][Full Text] [Related]
2. A photometric assay for blood coagulation factor XIII.
Fickenscher K; Aab A; Stüber W
Thromb Haemost; 1991 May; 65(5):535-40. PubMed ID: 1871715
[TBL] [Abstract][Full Text] [Related]
3. A modified, optimized kinetic photometric assay for the determination of blood coagulation factor XIII activity in plasma.
Kárpáti L; Penke B; Katona E; Balogh I; Vámosi G; Muszbek L
Clin Chem; 2000 Dec; 46(12):1946-55. PubMed ID: 11106327
[TBL] [Abstract][Full Text] [Related]
4. Kinetic determination of blood coagulation Factor XIII in plasma.
Muszbek L; Polgár J; Fésüs L
Clin Chem; 1985 Jan; 31(1):35-40. PubMed ID: 2856900
[TBL] [Abstract][Full Text] [Related]
5. Determination of factor XIII activity and of factor XIII inhibitors using an ammonium-sensitive electrode.
Hellstern P; Schilz K; von Blohn G; Wenzel E
Thromb Haemost; 1983 Aug; 50(2):563-6. PubMed ID: 6138878
[TBL] [Abstract][Full Text] [Related]
6. Role of blood coagulation factor XIII in patients with acute pulmonary embolism. Correlation of factor XIII antigen levels with pulmonary occlusion rate, fibrinogen, D-dimer, and clot firmness.
Kucher N; Schroeder V; Kohler HP
Thromb Haemost; 2003 Sep; 90(3):434-8. PubMed ID: 12958612
[TBL] [Abstract][Full Text] [Related]
7. A microtiter assay for factor XIII using fibrinogen and biotinylcadaverine as substrates.
Song YC; Sheng D; Taubenfeld SM; Matsueda GR
Anal Biochem; 1994 Nov; 223(1):88-92. PubMed ID: 7695107
[TBL] [Abstract][Full Text] [Related]
8. Microtiter assay for measurement of factor XIII activity in plasma.
Dempfle CE; Harenberg J; Hochreuter K; Heene DL
J Lab Clin Med; 1992 May; 119(5):522-8. PubMed ID: 1349910
[TBL] [Abstract][Full Text] [Related]
9. Quantification of coagulation factor XIII activity by a thio-NADH based assay using factor XIII immuno-depleted plasma as a diluent for calibration.
Kappel A; Stephan S; Christ G; Pechmann L; Duwe C; Fischer B; Hahn M; Althaus H; Ehm M; Schwarz H; Vitzthum F
Clin Chem Lab Med; 2010 Dec; 48(12):1739-43. PubMed ID: 20828366
[TBL] [Abstract][Full Text] [Related]
10. Increased risk for postoperative hemorrhage after intracranial surgery in patients with decreased factor XIII activity: implications of a prospective study.
Gerlach R; Tölle F; Raabe A; Zimmermann M; Siegemund A; Seifert V
Stroke; 2002 Jun; 33(6):1618-23. PubMed ID: 12053001
[TBL] [Abstract][Full Text] [Related]
11. Analytical and clinical utility of a photometric assay for blood coagulation factor XIII.
van Wersch JW
Eur J Clin Chem Clin Biochem; 1993 Jul; 31(7):467-71. PubMed ID: 8399788
[TBL] [Abstract][Full Text] [Related]
12. Cleavage of blood coagulation factor XIII and fibrinogen by thrombin during in vitro clotting.
Greenberg CS; Miraglia CC; Rickles FR; Shuman MA
J Clin Invest; 1985 May; 75(5):1463-70. PubMed ID: 2860124
[TBL] [Abstract][Full Text] [Related]
13. Determination of factor XIII activity by a new photometric assay in plasma and platelets of healthy blood donors.
Wagner B; Seyfert UT; Gosse M; Wenzel E; Fickenscher K; Ruhl HG
Thromb Res; 1994 Apr; 74(2):169-74. PubMed ID: 8029818
[TBL] [Abstract][Full Text] [Related]
14. Assessment of Factor XIII.
Muszbek L; Katona É; Kerényi A
Methods Mol Biol; 2017; 1646():277-293. PubMed ID: 28804836
[TBL] [Abstract][Full Text] [Related]
15. A photometric method for the dosage of factor XIII applied to the study of chronic hepatopathies.
Ballerini G; Gemmati D; Moratelli S; Morelli P; Serino ML
Thromb Res; 1995 Jun; 78(5):451-6. PubMed ID: 7660361
[TBL] [Abstract][Full Text] [Related]
16. A simple, quick one-step ELISA assay for the determination of complex plasma factor XIII (A2B2).
Katona E; Haramura G; Kárpáti L; Fachet J; Muszbek L
Thromb Haemost; 2000 Feb; 83(2):268-73. PubMed ID: 10739385
[TBL] [Abstract][Full Text] [Related]
17. Comparison of coagulation factor XIII content and concentration in cryoprecipitate and fresh-frozen plasma.
Caudill JS; Nichols WL; Plumhoff EA; Schulte SL; Winters JL; Gastineau DA; Rodriguez V
Transfusion; 2009 Apr; 49(4):765-70. PubMed ID: 19192257
[TBL] [Abstract][Full Text] [Related]
18. [Evaluation of coagulation factor XIII. Critical study of the different techniques used (author's transl)].
Soria J; Soria C; Lafay P
Pathol Biol (Paris); 1980 May; 28(5):313-7. PubMed ID: 6770323
[TBL] [Abstract][Full Text] [Related]
19. Investigation of a link between raised levels of pepsinogen in blood as a mediator of in-vitro clot lysis in acid and a cause of abnormal factor XIII screening tests.
Duncan EM; Dale BJ; Lloyd JV
Blood Coagul Fibrinolysis; 2014 Jun; 25(4):340-8. PubMed ID: 24440916
[TBL] [Abstract][Full Text] [Related]
20. Bleeding disorder with abnormal wound healing, acid-soluble clots and normal factor XIII.
Ragaz S; Kemp G; Furlan M; Beck EA
Thromb Haemost; 1976 Dec; 36(3):537-41. PubMed ID: 1037151
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
